A Narrative Review on the Role of Dalbavancin in the Treatment of Bone and Joint Infections

Bone and joint infections (BJI) require prolonged antimicrobial treatment, leading to lengthy hospitalizations, high costs, the risk of nosocomial infections, and the development of antimicrobial resistance. Dalbavancin is a novel semisynthetic lipoglycopeptide approved for the treatment of adults a...

Full description

Bibliographic Details
Main Authors: Dimitra Dimopoulou, Elpis Mantadakis, Christos Koutserimpas, George Samonis
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/12/10/1492